← Open Payments lookup

PAGE YIN: Open Payments

NPI 1174978126 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 35 payments from 11 companies in 2025. Trend: 2023 $729 · 2024 $670 · 2025 $1,352

Food & beverage: $1,226Education: $126
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$291
Axsome Therapeutics, Inc.2$250
E.R. Squibb & Sons, L.L.C.10$201
Alkermes, Inc.3$160
Madrigal Pharmaceuticals1$130
ABBVIE INC.5$127
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$67
Lundbeck LLC3$52
Otsuka America Pharmaceutical, Inc.2$32
Vanda Pharmaceuticals Inc.1$24

Products named: Auvelity, COBENFY, UZEDY, LYBALVI, REZDIFFRA, VRAYLAR, REXULTI, CAPLYTA.

Industry payments across NY — which companies pay providers there.